Skip to main content
Clinical Trials/NCT04384887
NCT04384887
Completed
Not Applicable

''(COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"

Kanuni Sultan Suleyman Training and Research Hospital1 site in 1 country100 target enrollmentApril 25, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Enrollment
100
Locations
1
Primary Endpoint
Evaluation of depression and anxiety score changes of covid-19 positive pregnants
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

In our study; Anxiety and depression levels, socio-demographic characteristics of the pregnant women who were admitted to our hospital between 25.04.2020-25.07.2020 and treated with the diagnosis of covid 19, and the change in anxiety and depression levelsWİTH Beck Depression and Anxiety Score after the disease regressed are planned.

(Beck depression scale contains 10 questions and a total of 1 to 100 points is obtained. High score indicates that depression and anxiety are high.) 0-16 points = mild depressive symptoms

17-29 points = moderate depressive symptoms

30-63 points = severe depressive symptoms

Detailed Description

The sociodemographic data form prepared by the researchers will be filled out by interviewing the patients who are willing to participate in the study. In addition, Beck Depression Scale, Beck Anxiety Scale, State and Trait Anxiety Scale will be given by the participants themselves. When the patients come to their first control after discharge, the scales specified will be repeated.

Registry
clinicaltrials.gov
Start Date
April 25, 2020
End Date
August 26, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pınar Yalcin bahat

Principal Investigator

Kanuni Sultan Suleyman Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • covid -19 pcr positive pregnant women
  • no psychiatric diagnosis no use of psychiatric medicine

Exclusion Criteria

  • Non-pregnant patients, A psychiatric diagnosis use of psychiatric medicine

Outcomes

Primary Outcomes

Evaluation of depression and anxiety score changes of covid-19 positive pregnants

Time Frame: 4 months

Evaluation of depression and anxiety score changes of covid-19 positive pregnants Pregnant women are questioned how this period was affected, as the pandemic period loaded with extra stress and caused depression and anxiety.

Study Sites (1)

Loading locations...

Similar Trials